Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0029 Transporter Info | ||||
Gene Name | SLCO1A2 | ||||
Protein Name | Organic anion transporting polypeptide 1A2 | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs3764043 | ||||
Site of GPD | chr12:21335070 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>T | ||||
Minor Allele Frequency | T=0.0877/439 (Global) | ||||
Genotype CC | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Imatinib | Drug Info | Bcr-Abl Positive Chronic Myelogenous Leukemia | Correlated with the decreased drug clearance in patients (compare with Genotypes CT + TT) | [ 1] | |
Genetic Polymorphism | rs3834939 | ||||
Site of GPD | chr12:21334836-21334838 (GRCh38.p12) | ||||
GPD Type | Indel Insertion and Deletion | ||||
Allele(s) in dbSNP | dupT | ||||
Minor Allele Frequency | T=0.3708/1857 (Global) | ||||
Genotypes T/del + TT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Rocuronium | Drug Info | Healthy Individuals | Correlated with the decreased drug clearance in healthy individuals (compare with genotype del/del) | [ 2] | |
References | |||||
1 | Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia. Clin Pharmacol Ther. 2011 Jul;90(1):157-63. | ||||
2 | The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. Eur J Clin Pharmacol. 2017 Aug;73(8):957-963. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.